Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue for treatment of COVID-19 outpatients
IRCT20191228045924N2Phase 4Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylene blue in coronavirus disease 2019 (COVID-19), sponsored by Mashhad University of Medical Sciences. Started Nov 2021; status: completed.
02
Drugs
methylene blue
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20191228045924N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191228045924N2.